Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial

SIMPLE SUMMARY: Hematological toxicity may be a consistent issue in anal cancer patients undergoing concurrent chemo-radiation, with a potentially detrimental effect on clinical outcomes and patient compliance to treatment. Chemotherapy is the most important trigger, since it induces myelosuppressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Arcadipane, Francesca, Silvetti, Patrick, Olivero, Francesco, Gastino, Alessio, De Luca, Viola, Mistrangelo, Massimiliano, Cassoni, Paola, Racca, Patrizia, Gallio, Elena, Lesca, Adriana, Fiandra, Christian, Ricardi, Umberto, Franco, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696305/
https://www.ncbi.nlm.nih.gov/pubmed/33182445
http://dx.doi.org/10.3390/cancers12113306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696305/
https://www.ncbi.nlm.nih.gov/pubmed/33182445
http://dx.doi.org/10.3390/cancers12113306

Ejemplares similares